Bill

Bill > HF2703


MN HF2703

MN HF2703
Prohibition extended on manufacturers interfering with access to 340B drugs.


summary

Introduced
03/24/2025
In Committee
03/24/2025
Crossed Over
Passed
Dead

Introduced Session

94th Legislature 2025-2026

Bill Summary

A bill for an act relating to drug manufacturers; extending a prohibition on manufacturers interfering with access to 340B drugs; repealing Minnesota Statutes 2024, section 62J.96, subdivision 3.

AI Summary

This bill repeals the expiration date for a Minnesota statute related to 340B drugs, effectively making the existing provisions permanent. The 340B Drug Pricing Program is a federal program that allows certain healthcare providers (like hospitals, clinics, and healthcare centers that serve vulnerable populations) to purchase outpatient drugs at significantly reduced prices. By removing the July 1, 2027 sunset date from section 62J.96, subdivision 3, the legislation ensures that current protections or regulations regarding access to 340B drugs will continue indefinitely, rather than automatically expiring on that date. This suggests that the state considers the existing provisions about 340B drug access important enough to maintain without a time limitation.

Committee Categories

Business and Industry

Sponsors (5)

Last Action

Author stricken Backer (on 04/02/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...